Pharma · Private company
Bausch Health Americas, Inc.
Track this companyFree. Adds Bausch Health Americas, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials2516 recruiting or active
Pipeline programs25From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline25
- IDP-118 LotionPhase 3 · Plaque PsoriasisClinicalTrials.gov · fetched Nov 12, 2026
- IDP-118 Vehicle LotionPhase 3 · Plaque PsoriasisClinicalTrials.gov · fetched Nov 12, 2026
- IDP-120 GelPhase 3 · Acne VulgarisClinicalTrials.gov · fetched Nov 12, 2026
- IDP-120 Vehicle GelPhase 3 · Acne VulgarisClinicalTrials.gov · fetched Nov 12, 2026
- IDP-121 LotionPhase 3 · AcneClinicalTrials.gov · fetched Nov 12, 2026
- IDP-121 Vehicle LotionPhase 3 · AcneClinicalTrials.gov · fetched Nov 12, 2026
- IDP-122 LotionPhase 3 · Plaque PsoriasisClinicalTrials.gov · fetched Nov 12, 2026
- IDP-122 Vehicle LotionPhase 3 · Plaque PsoriasisClinicalTrials.gov · fetched Nov 12, 2026
- LarsucosterolPhase 3 · HepatitisClinicalTrials.gov · fetched Nov 12, 2026
- PlecanatidePhase 3 · Irritable Bowel Syndrome Characterized by ConstipationClinicalTrials.gov · fetched Nov 12, 2026
- Rifaximin SSDPhase 3 · Hepatic EncephalopathyClinicalTrials.gov · fetched Nov 12, 2026
- plecanatidePhase 2 · Functional Constipation (FC)ClinicalTrials.gov · fetched Nov 12, 2026
- PlecanatidePhase 2 · Irritable Bowel Syndrome With ConstipationClinicalTrials.gov · fetched Nov 12, 2026
- BrodalumabPsoriasisClinicalTrials.gov · fetched Nov 12, 2026
- CABTREO is a fixed-combination product of clindamycin phosphate 1.2%/BPO 3.1%/adapalene 0.15%.Acne VulgarisClinicalTrials.gov · fetched Nov 12, 2026
- Comparator Drug (non-biologic IL-17 inhibitors)PsoriasisClinicalTrials.gov · fetched Nov 12, 2026
- Fraxel® FTX Laser SystemSkin ResurfacingClinicalTrials.gov · fetched Nov 12, 2026
- High Dose BudesonideUlcerative ColitisClinicalTrials.gov · fetched Nov 12, 2026
- IDP-118 LotionPsoriasisClinicalTrials.gov · fetched Nov 12, 2026
- IDP-122 LotionPsoriasisClinicalTrials.gov · fetched Nov 12, 2026
- Low Dose BudesonideUlcerative ColitisClinicalTrials.gov · fetched Nov 12, 2026
- Oral Rehydration Therapy (ORT)DiarrheaClinicalTrials.gov · fetched Nov 12, 2026
- PimecrolimusAtopic DermatitisClinicalTrials.gov · fetched Nov 12, 2026
- Rifaximin 200 mg TabletDiarrheaClinicalTrials.gov · fetched Nov 12, 2026
- Thermage FLXWrinkleClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials25
- This is a Randomized, Double-blind, Placebo-controlled, Multicenter, Parallel-group Study of the Efficacy and Safety of 2 Weight-based Treatment Groups of Plecanatide Versus Placebo in Children and Adolescent Participants 6 to Less Than 18 Years of Age With FCPHASE2 · ACTIVE_NOT_RECRUITING · started Aug 18, 2026ClinicalTrials.gov NCT07723924 · fetched Nov 12, 2026
- Study to Assess Safety, Pharmacokinetics, and Treatment Effect of CabtreoPHASE4 · RECRUITING · started Apr 1, 2026ClinicalTrials.gov NCT07524946 · fetched Nov 12, 2026
- Rifaximin 200 mg Plus Oral Rehydration vs Oral Rehydration Alone in Children With Acute DiarrheaPHASE4 · RECRUITING · started Feb 11, 2026ClinicalTrials.gov NCT07285785 · fetched Nov 12, 2026
- Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis (AH)PHASE3 · RECRUITING · started Jan 29, 2026ClinicalTrials.gov NCT07428538 · fetched Nov 12, 2026
- A Prospective Controlled Study to Evaluate the Safety and Effectiveness of Thermage® FLX Radiofrequency TreatmentNA · ACTIVE_NOT_RECRUITING · started Oct 31, 2025ClinicalTrials.gov NCT07187297 · fetched Nov 12, 2026
- A Phase 4 Clinical Study to Investigate the Effectiveness and Safety of Skin ResurfacingNA · ACTIVE_NOT_RECRUITING · started Oct 17, 2025ClinicalTrials.gov NCT07214272 · fetched Nov 12, 2026
- Brodalumab in the Treatment of Immune-Related Adverse EventsPHASE1 · RECRUITING · started Mar 11, 2025ClinicalTrials.gov NCT06673329 · fetched Nov 12, 2026
- Rifaximin for the Secondary Prevention of Recurrent PouchitisPHASE4 · RECRUITING · started Jul 1, 2024ClinicalTrials.gov NCT06312683 · fetched Nov 12, 2026
- Experience With Topical Acne TreatmentEARLY_PHASE1 · ACTIVE_NOT_RECRUITING · started Feb 15, 2024ClinicalTrials.gov NCT05582434 · fetched Nov 12, 2026
- Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Extended-release Tablets in Pediatric Subjects Aged 5 to 17 Years With Active, Mild to Moderate Ulcerative ColitisPHASE4 · RECRUITING · started Sep 29, 2023ClinicalTrials.gov NCT04314375 · fetched Nov 12, 2026
- Duobrii Treatment of Acne Keloidalis Nuchae (AKN)PHASE3 · TERMINATED · started Oct 26, 2022ClinicalTrials.gov NCT05608499 · fetched Nov 12, 2026
- Evaluation of Rifaximin SSD for Delaying Encephalopathy Decompensation in Patients With CirrhosisPHASE3 · COMPLETED · started Aug 3, 2022ClinicalTrials.gov NCT05297448 · fetched Nov 12, 2026
- Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in CirrhosisPHASE3 · ACTIVE_NOT_RECRUITING · started Apr 7, 2022ClinicalTrials.gov NCT05071716 · fetched Nov 12, 2026
- Influence of SRP With MM on the Composition and Functional Characteristics of Subgingival Microbiome CommunitiesNA · ACTIVE_NOT_RECRUITING · started Oct 15, 2021ClinicalTrials.gov NCT05422742 · fetched Nov 12, 2026
- A Safety and Pharmacokinetics Study of IDP-118 Lotion in Pediatric Participants With Plaque PsoriasisPHASE4 · COMPLETED · started Mar 24, 2021ClinicalTrials.gov NCT03988439 · fetched Nov 12, 2026
- An Open-label, Single-dose Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Brodalumab in Pediatric SubjectsPHASE4 · ACTIVE_NOT_RECRUITING · started Jan 24, 2020ClinicalTrials.gov NCT03240809 · fetched Nov 12, 2026
- A Safety and Pharmacokinetics Study of IDP-122 Lotion in Pediatric Participants With Plaque PsoriasisPHASE4 · ACTIVE_NOT_RECRUITING · started Oct 22, 2019ClinicalTrials.gov NCT03987763 · fetched Nov 12, 2026
- Study Comparing the Safety and Efficacy of IDP-120 Gel and IDP-120 Vehicle Gel in the Treatment of Participants With Acne VulgarisPHASE3 · COMPLETED · started Dec 10, 2018ClinicalTrials.gov NCT03664752 · fetched Nov 12, 2026
- Efficacy and Safety of Plecanatide in Children 6 to <18 Years With Irritable Bowel Syndrome With Constipation (IBS-C)PHASE2 · COMPLETED · started Jun 30, 2018ClinicalTrials.gov NCT03596905 · fetched Nov 12, 2026
- LTS of Siliq vs. Other Therapies Treating of Adults With Moderate-to-Severe PsoriasisENROLLING_BY_INVITATION · started Jul 25, 2017ClinicalTrials.gov NCT03254667 · fetched Nov 12, 2026
- Safety and Efficacy of IDP-122 in Participants With Plaque PsoriasisPHASE3 · COMPLETED · started Nov 5, 2015ClinicalTrials.gov NCT02515097 · fetched Nov 12, 2026
- Efficacy and Safety of IDP-121 and IDP-121 Vehicle Lotion in the Treatment of Participants With Acne VulgarisPHASE3 · COMPLETED · started Nov 3, 2015ClinicalTrials.gov NCT02932306 · fetched Nov 12, 2026
- Safety and Efficacy of IDP-118 in Participants With Plaque PsoriasisPHASE3 · COMPLETED · started Aug 19, 2015ClinicalTrials.gov NCT02462122 · fetched Nov 12, 2026
- The Plecanatide Irritable Bowel Syndrome With Constipation Safety and Efficacy Study (IBS-C)PHASE3 · COMPLETED · started Dec 1, 2014ClinicalTrials.gov NCT02387359 · fetched Nov 12, 2026
- 10 Year Registry of Children (Ages 2-17 Years) With Eczema That Have Used PimecrolimusACTIVE_NOT_RECRUITING · started Jun 27, 2005ClinicalTrials.gov NCT00568997 · fetched Nov 12, 2026